Geode Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.9M | Sell |
427,546
-2,080
| -0.5% | -$136K | ﹤0.01% | 1782 |
|
2025
Q1 | $28.8M | Buy |
429,626
+627
| +0.1% | +$42K | ﹤0.01% | 1696 |
|
2024
Q4 | $23.7M | Buy |
428,999
+3,774
| +0.9% | +$209K | ﹤0.01% | 1886 |
|
2024
Q3 | $25.4M | Buy |
425,225
+17,314
| +4% | +$1.03M | ﹤0.01% | 1849 |
|
2024
Q2 | $26M | Buy |
407,911
+68,547
| +20% | +$4.37M | ﹤0.01% | 1786 |
|
2024
Q1 | $23.5M | Buy |
339,364
+9,675
| +3% | +$669K | ﹤0.01% | 1822 |
|
2023
Q4 | $18.2M | Buy |
329,689
+8,368
| +3% | +$461K | ﹤0.01% | 1972 |
|
2023
Q3 | $18.7M | Buy |
321,321
+57,620
| +22% | +$3.35M | ﹤0.01% | 1868 |
|
2023
Q2 | $14.2M | Buy |
263,701
+18,596
| +8% | +$1M | ﹤0.01% | 2079 |
|
2023
Q1 | $9.74M | Buy |
245,105
+5,756
| +2% | +$229K | ﹤0.01% | 2270 |
|
2022
Q4 | $9.63M | Buy |
239,349
+10,557
| +5% | +$425K | ﹤0.01% | 2288 |
|
2022
Q3 | $7.35M | Sell |
228,792
-3,053
| -1% | -$98.1K | ﹤0.01% | 2451 |
|
2022
Q2 | $6.88M | Buy |
231,845
+35,929
| +18% | +$1.07M | ﹤0.01% | 2510 |
|
2022
Q1 | $5.51M | Sell |
195,916
-7,537
| -4% | -$212K | ﹤0.01% | 2740 |
|
2021
Q4 | $9.38M | Buy |
203,453
+40,416
| +25% | +$1.86M | ﹤0.01% | 2482 |
|
2021
Q3 | $5.35M | Sell |
163,037
-10,385
| -6% | -$341K | ﹤0.01% | 2874 |
|
2021
Q2 | $6.08M | Buy |
173,422
+13,408
| +8% | +$470K | ﹤0.01% | 2781 |
|
2021
Q1 | $5.78M | Buy |
160,014
+19,600
| +14% | +$708K | ﹤0.01% | 2717 |
|
2020
Q4 | $4.08M | Sell |
140,414
-4,586
| -3% | -$133K | ﹤0.01% | 2707 |
|
2020
Q3 | $4.09M | Buy |
145,000
+4,868
| +3% | +$137K | ﹤0.01% | 2518 |
|
2020
Q2 | $4.53M | Buy |
140,132
+3,856
| +3% | +$125K | ﹤0.01% | 2391 |
|
2020
Q1 | $5.55M | Buy |
136,276
+11,354
| +9% | +$462K | ﹤0.01% | 2085 |
|
2019
Q4 | $7.7M | Buy |
124,922
+8,125
| +7% | +$501K | ﹤0.01% | 2187 |
|
2019
Q3 | $8.51M | Buy |
116,797
+784
| +0.7% | +$57.1K | ﹤0.01% | 2044 |
|
2019
Q2 | $9.54M | Buy |
116,013
+10,052
| +9% | +$826K | ﹤0.01% | 1995 |
|
2019
Q1 | $7.47M | Buy |
105,961
+8,502
| +9% | +$600K | ﹤0.01% | 2090 |
|
2018
Q4 | $4.39M | Buy |
97,459
+2,827
| +3% | +$127K | ﹤0.01% | 2298 |
|
2018
Q3 | $5.35M | Buy |
94,632
+7,298
| +8% | +$413K | ﹤0.01% | 2317 |
|
2018
Q2 | $5.83M | Buy |
87,334
+4,024
| +5% | +$269K | ﹤0.01% | 2235 |
|
2018
Q1 | $4.85M | Buy |
83,310
+6,332
| +8% | +$369K | ﹤0.01% | 2251 |
|
2017
Q4 | $4.96M | Buy |
76,978
+10,430
| +16% | +$672K | ﹤0.01% | 2222 |
|
2017
Q3 | $3.49M | Buy |
66,548
+1,201
| +2% | +$63K | ﹤0.01% | 2415 |
|
2017
Q2 | $3.06M | Buy |
65,347
+969
| +2% | +$45.3K | ﹤0.01% | 2473 |
|
2017
Q1 | $3.19M | Buy |
64,378
+2,816
| +5% | +$139K | ﹤0.01% | 2388 |
|
2016
Q4 | $3.73M | Buy |
61,562
+5,950
| +11% | +$361K | ﹤0.01% | 2254 |
|
2016
Q3 | $3.69M | Buy |
55,612
+767
| +1% | +$50.9K | ﹤0.01% | 2155 |
|
2016
Q2 | $3.06M | Buy |
54,845
+1,624
| +3% | +$90.6K | ﹤0.01% | 2206 |
|
2016
Q1 | $1.79K | Buy |
53,221
+543
| +1% | +$18 | ﹤0.01% | 2537 |
|
2015
Q4 | $2.38M | Buy |
52,678
+30
| +0.1% | +$1.35K | ﹤0.01% | 2350 |
|
2015
Q3 | $2.08M | Buy |
52,648
+1,645
| +3% | +$65K | ﹤0.01% | 2421 |
|
2015
Q2 | $3.16M | Buy |
51,003
+1,923
| +4% | +$119K | ﹤0.01% | 2213 |
|
2015
Q1 | $3.07M | Buy |
49,080
+2,402
| +5% | +$150K | ﹤0.01% | 2165 |
|
2014
Q4 | $2.63M | Buy |
46,678
+10,216
| +28% | +$576K | ﹤0.01% | 2252 |
|
2014
Q3 | $1.03M | Buy |
36,462
+1,163
| +3% | +$32.9K | ﹤0.01% | 2759 |
|
2014
Q2 | $1.22M | Buy |
35,299
+4,876
| +16% | +$168K | ﹤0.01% | 2676 |
|
2014
Q1 | $953K | Buy |
30,423
+443
| +1% | +$13.9K | ﹤0.01% | 2821 |
|
2013
Q4 | $601K | Buy |
29,980
+1,196
| +4% | +$24K | ﹤0.01% | 2995 |
|
2013
Q3 | $281K | Buy |
28,784
+15,158
| +111% | +$148K | ﹤0.01% | 3173 |
|
2013
Q2 | $82K | Buy |
+13,626
| New | +$82K | ﹤0.01% | 3453 |
|